Samuel Pine

1.0k total citations
14 papers, 715 citations indexed

About

Samuel Pine is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Samuel Pine has authored 14 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Samuel Pine's work include Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune Response and Inflammation (4 papers). Samuel Pine is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune Response and Inflammation (4 papers). Samuel Pine collaborates with scholars based in United States, Switzerland and Belgium. Samuel Pine's co-authors include Rhea N. Coler, Steven G. Reed, Susan L. Baldwin, Sylvie Bertholet, Hillarie Plessner Windish, Maria Kahn, M. Juliana McElrath, Pierre–Yves Bochud, Diane Ordway and Ian M. Orme and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Biophysical Journal.

In The Last Decade

Samuel Pine

13 papers receiving 706 citations

Peers

Countries citing papers authored by Samuel Pine

Since Specialization

Citations

This map shows the geographic impact of Samuel Pine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Pine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Pine more than expected).

Fields of papers citing papers by Samuel Pine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Pine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Pine. The network helps show where Samuel Pine may publish in the future.

Co-authorship network of co-authors of Samuel Pine

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Pine. A scholar is included among the top collaborators of Samuel Pine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Pine. Samuel Pine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Cloud Solutions for GxP Laboratories: Considerations for Data Storage 2021 ·Bioanalysis ·S. Scott Davis, Joel Usansky, Shibani Mitra‐Kaushik, John F. Kellie, (unknown), Eric Woolf, (unknown), (unknown), (unknown), Samuel Pine, (unknown), (unknown), (unknown), (unknown)	3
2	An innovative method for characterizing neutralizing antibodies against antibody-derived therapeutics 2020 ·Journal of Immunological Methods ·Annelies Coddens, Veerle Snoeck, (unknown), Marie-Ange Buyse, Samuel Pine	5
3	European Immunogenicity Platform 11th Open Scientific Symposium on Immunogenicity of Biopharmaceuticals 2020 ·Bioanalysis ·Sophie Tourdot, (unknown), Paul Chamberlain, Anne S. De Groot, Nikki Dellas, Eric Guillemare, Arno Kromminga, Gregor P. Lotz, Federico Mingozzi, Luca Piccoli, Samuel Pine, Susan Richards, (unknown), Daniel Kramer	1
4	Design and Conduct Considerations for First‐in‐Human Trials 2018 ·Clinical and Translational Science ·Jie Shen, Brandon Swift, Richard D. Mamelok, Samuel Pine, John Sinclair, Mayssa Attar	92
5	The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction 2016 ·PLoS ONE ·Natasha Dubois Cauwelaert, Anthony L. Desbien, Thomas E. Hudson, Samuel Pine, Steven G. Reed, Rhea N. Coler, Mark T. Orr	41
6	The TLR4 agonist vaccine adjuvant, GLA-SE, requires canonical and atypical mechanisms of action for TH1 induction 2016 ·The Journal of Immunology ·Natasha Dubois Cauwelaert, Anthony L. Desbien, (unknown), Samuel Pine, Steven G. Reed, Rhea N. Coler, Mark T. Orr	3
7	Protection against Tuberculosis with Homologous or Heterologous Protein/Vector Vaccine Approaches Is Not Dependent on CD8+ T Cells 2013 ·The Journal of Immunology ·Susan L. Baldwin, Lance Ching, Samuel Pine, Magdalini Moutaftsi, (unknown), Aarthy C. Vallur, Mark T. Orr, Sylvie Bertholet, Steven G. Reed, Rhea N. Coler	29
8	Therapeutic Immunization against Mycobacterium tuberculosis Is an Effective Adjunct to Antibiotic Treatment 2012 ·The Journal of Infectious Diseases ·Rhea N. Coler, Sylvie Bertholet, Samuel Pine, Mark T. Orr, Valerie A. Reese, Hillarie Plessner Windish, Charles L. Davis, Maria Kahn, Susan L. Baldwin, Steven G. Reed	81
9	Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans 2011 ·PLoS ONE ·Samuel Pine, James G. Kublin, Scott M. Hammer, Joleen Borgerding, Yunda Huang, Danilo R. Casimiro, M. Juliana McElrath	35
10	A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis 2010 ·Vaccine ·Evaldo Nascimento, (unknown), (unknown), Antonio Campos‐Neto, Jill A. Ashman, Fabiana Alves, Rhea N. Coler, Lisa Bogatzki, Stuart J. Kahn, Anna Marie Beckmann, Samuel Pine, Karen Cowgill, Steven G. Reed, Franco M. Piazza	59
11	A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis 2010 ·Science Translational Medicine ·Sylvie Bertholet, Gregory C. Ireton, Diane Ordway, Hillarie Plessner Windish, Samuel Pine, Maria Kahn, Tony Phan, Ian M. Orme, Thomas S. Vedvick, Susan L. Baldwin, Rhea N. Coler, Steven G. Reed	247
12	Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals 2009 ·AIDS ·Samuel Pine, M. Juliana McElrath, Pierre–Yves Bochud	70
13	Short Class I Major Histocompatibility Complex Cytoplasmic Tails Differing in Charge Detect Arbiters of Lateral Diffusion in the Plasma Membrane 2004 ·Biophysical Journal ·(unknown), Samuel Pine, Michael Edidin, Martha C. Zúñiga	21
14	Oral Administration of Influenza Vaccine in Combination with the Adjuvants LT-K63 and LT-R72 Induces Potent Immune Responses Comparable to or Stronger than Traditional Intramuscular Immunization 2001 ·Clinical and Diagnostic Laboratory Immunology ·(unknown), Gary Ott, Samuel Pine, Derek T. O’Hagan	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact